 WOODCLIFF LAKE, N.J., March 05, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Timber Pharmaceuticals, Inc. Timber or the Company NYSE American: TMBR, a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that Timbers Chief Executive Officer John Koconis will present a corporate overview at the virtual 2021 H.C. Wainwright Global Life Sciences Conference being held on March 9-10, 2021. 